A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
Clinical trial NCT05193188 · UNKNOWN
Trial details
- NCT number
- NCT05193188
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2025-03-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.